{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:59:36Z","timestamp":1790002776673,"version":"4.0.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,21]]},"DOI":"10.7759\/cureus.116644","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:59:30Z","timestamp":1789999170000},"source":"Crossref","is-referenced-by-count":0,"title":["Maternal Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Vaccination in Panama: A Retrospective Follow-Up Study"],"prefix":"10.7759","author":[{"given":"Ana","family":"Lucas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"De Antonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Fernandez Camargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Peralta Alvarado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Escobar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belen","family":"Ricci Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Alberto","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Gadea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Barrios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Guillen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"De Avila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime Ricardo","family":"Sevillano Giraldez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis","volume":"399","author":"Li Y","year":"2022","unstructured":"Li Y, Wang X, Blau DM, et al.. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. 2022, 399:2047-64. 10.1016\/S0140-6736(22)00478-0","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2022.100304","article-title":"Incidence of respiratory virus illness and hospitalizations in a Panama and El Salvador birth cohort, 2014-2018","volume":"13","author":"Azziz-Baumgartner E","year":"2022","unstructured":"Azziz-Baumgartner E, Duca LM, Gonz\u00e1lez R, et al.. Incidence of respiratory virus illness and hospitalizations in a Panama and El Salvador birth cohort, 2014-2018. Lancet Reg Health Am. 2022, 13:100304. 10.1016\/j.lana.2022.100304","journal-title":"Lancet Reg Health Am"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/irv.70173","article-title":"Genomic insights into respiratory syncytial virus circulation patterns and neutralization by anti-F monoclonal antibodies in Panama (2018-2024)","volume":"19","author":"Franco D","year":"2025","unstructured":"Franco D, Goya S, Mart\u00ednez A, et al.. Genomic insights into respiratory syncytial virus circulation patterns and neutralization by anti-F monoclonal antibodies in Panama (2018-2024). Influenza Other Respir Viruses. 2025, 19:e70173. 10.1111\/irv.70173","journal-title":"Influenza Other Respir Viruses"},{"key":"ref4","unstructured":"Ministerio de Salud de la Rep\u00fablica de Panam\u00e1. Launch of the vaccination campaign against respiratory syncytial virus. (Article in Spanish). (2025). Accessed. August 19, 2026: https:\/\/minsa.gob.pa\/noticia\/lanzamiento-de-la-campana-de-vacunacion-contra-el-virus-sincitial-respiratorio."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2216480","article-title":"Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants","volume":"388","author":"Kampmann B","year":"2023","unstructured":"Kampmann B, Madhi SA, Munjal I, et al.. Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants. N Engl J Med. 2023, 388:1451-64. 10.1056\/NEJMoa2216480","journal-title":"N Engl J Med"},{"key":"ref6","unstructured":"World Health Organization. WHO position paper on immunization to protect infants against respiratory syncytial virus disease, May 2025. (2025). https.\/\/www.who.int\/publications\/i\/item\/who-wer-10022-193-218."},{"key":"ref7","unstructured":"Pan American Health Organization. Recommendations for the use of immunization products against respiratory syncytial virus (RSV). (2025). Accessed. August 19, 2026: https:\/\/www.paho.org\/sites\/default\/files\/2026\/01\/recommendations-use-immunization-products-against-respiratory-syncyt...."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(25)00156-2","article-title":"Real-world effectiveness of RSVpreF vaccination during pregnancy against RSV-associated lower respiratory tract disease leading to hospitalisation in infants during the 2024 RSV season in Argentina (BERNI study): a multicentre, retrospective, test-negative, case-control study","volume":"25","author":"P\u00e9rez Marc G","year":"2025","unstructured":"P\u00e9rez Marc G, Vizzotti C, Fell DB, et al.. Real-world effectiveness of RSVpreF vaccination during pregnancy against RSV-associated lower respiratory tract disease leading to hospitalisation in infants during the 2024 RSV season in Argentina (BERNI study): a multicentre, retrospective, test-negative, case-control study. Lancet Infect Dis. 2025, 25:1044-54. 10.1016\/S1473-3099(25)00156-2","journal-title":"Lancet Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000004878","article-title":"Maternal immunization with RSVpreF vaccine: effectiveness in preventing respiratory syncytial virus-associated hospitalizations in infants under 6 months in Argentina: multicenter case-control study","volume":"44","author":"Gentile A","year":"2025","unstructured":"Gentile A, Ju\u00e1rez MD, Lucion MF, et al.. Maternal immunization with RSVpreF vaccine: effectiveness in preventing respiratory syncytial virus-associated hospitalizations in infants under 6 months in Argentina: multicenter case-control study. Pediatr Infect Dis J. 2025, 44:988-94. 10.1097\/INF.0000000000004878","journal-title":"Pediatr Infect Dis J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000005817","article-title":"Preterm birth frequency and associated outcomes from the MATISSE (Maternal Immunization Study for Safety and Efficacy) maternal trial of the bivalent respiratory syncytial virus prefusion F protein vaccine","volume":"145","author":"Madhi SA","year":"2025","unstructured":"Madhi SA, Kampmann B, Sim\u00f5es EA, et al.. Preterm birth frequency and associated outcomes from the MATISSE (Maternal Immunization Study for Safety and Efficacy) maternal trial of the bivalent respiratory syncytial virus prefusion F protein vaccine. Obstet Gynecol. 2025, 145:147-56. 10.1097\/AOG.0000000000005817","journal-title":"Obstet Gynecol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.20944\/preprints202608.1049.v1","article-title":"Safety profile of the bivalent RSVpreF vaccine (Abrysvo\u00ae) administered during pregnancy: an active real-world pharmacovigilance study in Panama, 2025","author":"Quintero AL","year":"2026","unstructured":"Quintero AL, DeAntonio Suarez R, Fern\u00e1ndez Camargo I, et al.. Safety profile of the bivalent RSVpreF vaccine (Abrysvo\u00ae) administered during pregnancy: an active real-world pharmacovigilance study in Panama, 2025. Preprints. 2026, 2026081049. 10.20944\/preprints202608.1049.v1","journal-title":"Preprints"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm E","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007, 370:1453-7. 10.1016\/S0140-6736(07)61602-X","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0258(19980430)17:8<857::aid-sim777>3.0.co;2-e","article-title":"Two-sided confidence intervals for the single proportion: comparison of seven methods","volume":"17","author":"Newcombe RG","year":"1998","unstructured":"Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med. 1998, 17:857-72. 10.1002\/(sici)1097-0258(19980430)17:8&lt;857::aid-sim777&gt;3.0.co;2-e","journal-title":"Stat Med"},{"key":"ref14","unstructured":"R Core Team. R. A language and environment for statistical computing. (2026). Accessed: August 19, 2026: https:\/\/www.R-project.org\/."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.21105\/joss.01686","article-title":"Welcome to the Tidyverse","volume":"4","author":"Wickham H","year":"2019","unstructured":"Wickham H, Averick M, Bryan J, et al.. Welcome to the Tidyverse. J Open Source Softw. 2019, 4:1686. 10.21105\/joss.01686","journal-title":"J Open Source Softw"},{"key":"ref16","article-title":"Safety of respiratory syncytial virus vaccine in pregnant women. (Article in Spanish)","volume":"85","author":"Scruzzi GF","year":"2025","unstructured":"Scruzzi GF, Franchini CG, Giorgetti AC, et al.. Safety of respiratory syncytial virus vaccine in pregnant women. (Article in Spanish). Medicina (B Aires). 2025, 85:999-1007.","journal-title":"Medicina (B Aires)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000006121","article-title":"Maternal and neonatal outcomes after respiratory syncytial virus prefusion F protein vaccination during pregnancy: analysis from the 2024-2025 immunization campaign in France","volume":"147","author":"Gabet A","year":"2026","unstructured":"Gabet A, Bertrand M, Jabagi MJ, Kolla E, Oli\u00e9 V, Zureik M. Maternal and neonatal outcomes after respiratory syncytial virus prefusion F protein vaccination during pregnancy: analysis from the 2024-2025 immunization campaign in France. Obstet Gynecol. 2026, 147:118-26. 10.1097\/AOG.0000000000006121","journal-title":"Obstet Gynecol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2026.6190","article-title":"Sequential safety surveillance of RSVpreF vaccination during pregnancy early in the postapproval period","volume":"9","author":"Michnick AI","year":"2026","unstructured":"Michnick AI, MacDonald SC, Adimadhyam S, et al.. Sequential safety surveillance of RSVpreF vaccination during pregnancy early in the postapproval period. JAMA Netw Open. 2026, 9:e266190. 10.1001\/jamanetworkopen.2026.6190","journal-title":"JAMA Netw Open"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000006354","article-title":"Association of respiratory syncytial virus vaccination during pregnancy with adverse obstetric and neonatal outcomes","author":"DeSilva M","year":"2026","unstructured":"DeSilva M, Haapala J, Kharbanda EO, et al.. Association of respiratory syncytial virus vaccination during pregnancy with adverse obstetric and neonatal outcomes. Obstet Gynecol. 2026, 10.1097\/AOG.0000000000006354","journal-title":"Obstet Gynecol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/532059-maternal-bivalent-respiratory-syncytial-virus-prefusion-f-rsvpref-vaccination-in-panama-a-retrospective-follow-up-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:59:33Z","timestamp":1789999173000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/532059-maternal-bivalent-respiratory-syncytial-virus-prefusion-f-rsvpref-vaccination-in-panama-a-retrospective-follow-up-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.116644","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,21]]}}}